The BSE Sensex in India exhibited indecisiveness before closing modestly lower at 84,482 on Thursday, marking its fourth consecutive day of losses. This trend mirrored a global air of caution, as investors awaited the pivotal US inflation report that could potentially influence the Federal Reserve's monetary policy. Meanwhile, ongoing concerns surrounding trade negotiations persisted, although an uptick in the rupee and emerging signs of renewed interest from foreign investors provided some relief to the market sentiment. Among the sectors, Sun Pharma suffered the most significant decline, falling 2.7% after the US drug regulator's inspection of its Baska facility resulted in an “Official Action Indicated” status due to severe compliance issues. Conversely, IT stocks fared well, with TCS gaining 2%. The country's largest IT services provider announced a strategic plan to position itself as the global leader in AI-driven technology services, leading the sector's performance.
The material has been provided by - RobotFX.Org
Download NOW!
No comments:
Post a Comment